Specifically, GBM cells secrete IL-6, which persistently activates the JAK2/STAT3 signaling cascade, while TGF-β may synergistically enhance this immunosuppressive effect, leading to elevated expression of IL-10, VEGF, and CD163 in TAMs. The gene discussed is CD163; the disease is glioblastoma.